# Tennessee Lawmaker Advocates Special Session on Medical Marijuana > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/2026-tennessee-cannabis-legislation-special-session-push/ > **Published:** 2026-04-23T10:06:17-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:14:44-04:00 > **Clinical Summary:** Explore the 2026 Tennessee cannabis legislation push for a special session on medical marijuana and its impact on patient access and policy. --- ✦ New CED Clinical Relevance  #76Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic PolicyAccessMedical CannabisState LegislationPatient Access Why This Matters Tennessee remains one of the few states without comprehensive medical cannabis access, limiting treatment options for patients with qualifying conditions who might benefit from [cannabis-based therapies](https://cedclinic.com/cannabinoids-inhibit-keratinocyte-proliferation-non-cb1-cb2/). Legislative momentum in restrictive states often signals broader shifts in medical cannabis acceptance and eventual patient access. Clinical Summary A Tennessee lawmaker is advocating for a special legislative session to advance medical marijuana legislation in a state that currently maintains restrictive cannabis policies. Tennessee has limited CBD access for specific conditions but lacks a comprehensive medical cannabis program. The push reflects ongoing state-level policy discussions about medical cannabis access, which varies significantly across jurisdictions and affects patient treatment options. Dr. Caplan’s Take “Every delay in evidence-based policy means patients continue traveling across state lines or going without potentially helpful treatments. The clinical question isn’t whether cannabis works — it’s whether we’ll let geography determine medical access.” Clinical Perspective 🧠 Clinicians in restrictive states should stay informed about evolving local policies while continuing to provide evidence-based guidance about [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) to patients. Patients may benefit from understanding their options within current legal frameworks while advocacy efforts continue. Policy changes typically involve lengthy implementation periods, so immediate clinical practice remains unchanged. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Tennessee%20lawmaker%20pushing%20for%20special%20session%20on%20medical%20marijuana.%20%27What%20are%20w...%20%40drcaplan&url=https%3A//www.wsmv.com/2026/04/22/tennessee-lawmaker-pushing-special-session-medical-marijuana-what-are-we-waiting/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.wsmv.com/2026/04/22/tennessee-lawmaker-pushing-special-session-medical-marijuana-what-are-we-waiting/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Tennessee%20lawmaker%20pushing%20for%20special%20session%20on%20medical%20marijuana.%20%27What%20are%20w...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.wsmv.com/2026/04/22/tennessee-lawmaker-pushing-special-session-medical-marijuana-what-are-we-waiting/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.wsmv.com/2026/04/22/tennessee-lawmaker-pushing-special-session-medical-marijuana-what-are-we-waiting/](https://www.wsmv.com/2026/04/22/tennessee-lawmaker-pushing-special-session-medical-marijuana-what-are-we-waiting/) Table of Contents - [FAQ](#FAQ)[What type of clinical relevance does this update have?](#What_type_of_clinical_relevance_does_this_update_have) - [What categories does this cannabis news cover?](#What_categories_does_this_cannabis_news_cover) - [Why is this considered emerging information?](#Why_is_this_considered_emerging_information) - [How does this relate to medical cannabis access?](#How_does_this_relate_to_medical_cannabis_access) - [What should clinicians do with this information?](#What_should_clinicians_do_with_this_information) - [Related](#Related) ## FAQ #### What type of clinical relevance does this update have? This update has been classified as “Notable Clinical Interest” with a CED Clinical Relevance rating of #76. It represents emerging findings or policy developments that warrant close monitoring by healthcare professionals. #### What categories does this cannabis news cover? This update covers multiple important areas including policy changes, access issues, medical cannabis developments, and state legislation. These interconnected topics reflect the evolving landscape of cannabis regulation and [healthcare policy](https://cedclinic.com/cannabis-legalization-in-canada-new-opportunities/). #### Why is this considered emerging information? The content is marked as “New” and categorized under emerging findings, indicating recent developments in cannabis policy or clinical practice. Healthcare providers should stay informed about these evolving changes that may impact patient care. #### How does this relate to medical cannabis access? The update specifically highlights access-related developments in medical cannabis policy. This suggests changes that could affect how patients obtain or use medical cannabis treatments. #### What should clinicians do with this information? Given its “Notable Clinical Interest” designation, clinicians should monitor these developments closely. The emerging nature of these policy changes may require updates to clinical practices or patient counseling approaches. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Medical Marijuana Laws May Change in Georgia – Majic ATL](https://cedclinic.com/georgia-medical-cannabis-access-barriers-thc-cap-removal/) Learn about recent changes in medical marijuana laws in Georgia and how they may influence regional cannabis policy. [Read More](https://cedclinic.com/georgia-medical-cannabis-access-barriers-thc-cap-removal/) [Mississippi medical cannabis bills head to governor's desk – WLBT](https://cedclinic.com/mississippi-medical-cannabis-program-legislation/) Stay informed on Mississippi's medical cannabis legislative progress and its implications for patient access. [Explore Update](https://cedclinic.com/mississippi-medical-cannabis-program-legislation/) [Could Indiana be getting closer to legalizing cannabis? | wthr.com](https://cedclinic.com/indiana-cannabis-policy-progress-legalization/) Review the latest developments in Indiana's [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) efforts and potential impacts on medical access. [Learn More](https://cedclinic.com/indiana-cannabis-policy-progress-legalization/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).